REQUEST A DEMO
Total
USD $0.00
Search more companies

4Emed Sp. z o.o. sp. k. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores | All Other Miscellaneous Store Retailers | All Other Miscellaneous Schools and Instruction
Full name: 4Emed Sp. z o.o. sp. k. Profile Updated: September 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

4Emed Sp. z o.o. sp. k. is a company based in Poland, with its head office in Cisek. The company operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. The company was established on February 19, 2018. The company’s latest financial report indicates a net sales revenue drop of 36.54% in 2023. There was a total negative growth of 13.09% in 4Emed Sp. z o.o. sp. k.’s total assets over the same period. In, 2023, the company’s net profit margin decreased by 8.64%.

Headquarters
Ul. Mickiewicza 59
Cisek; Opolskie; Postal Code: 47-253

Contact Details: Purchase the 4Emed Sp. z o.o. sp. k. report to view the information.

Basic Information
Financial Auditors:
Purchase the 4Emed Sp. z o.o. sp. k. report to view the information.
Incorporation Date:
February 19, 2018
Company Performance
Financial values in the chart are available after 4Emed Sp. z o.o. sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-36.54%
Total operating revenue
-37.46%
Operating profit (EBIT)
-65%
EBITDA
-65%
Net Profit (Loss) for the Period
-65.13%
Total Assets
-13.09%
Total Equity
-80.95%
Operating Profit Margin (ROS)
-9.45%
Net Profit Margin
-8.64%
Return on Equity (ROE)
39.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?